Commonwealth Equity Services
ALZN icon

Commonwealth Equity Services’s Alzamend Neuro ALZN Stock Holding History

Commonwealth Equity Services’s Portfolio ALZN Stock Details ALZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-12
Closed -$4K – 3903
2023
Q3 		$4K Hold
12
– – ﹤0.01% 3807
2023
Q2 		$9K Hold
12
– – ﹤0.01% 3794
2023
Q1 		$7 Hold
12
– – ﹤0.01% 3734
2022
Q4 		$9K Hold
12
– – ﹤0.01% 3650
2022
Q3 		$19K Hold
12
– – ﹤0.01% 3584
2022
Q2 		$14K Hold
12
– – ﹤0.01% 3601
2022
Q1 		$20K Sell
12
-74
-86% -$139K ﹤0.01% 3658
2021
Q4 		$221K Buy
+86
New +$266K ﹤0.01% 3216

Other funds holding ALZN

Truist Financial
Truist Financial Charlotte, North Carolina $74.2B AUM 21.09% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
RA
RFG Advisory Birmingham, Alabama $6.4B AUM 19.93% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
HIA
Harbor Investment Advisory Lutherville, Maryland $1.43B AUM 30.71% 1-Year Est. Return

Commonwealth Equity Services's ALZN Position: Q4 2023 in Review

Commonwealth Equity Services sold out of Alzamend Neuro (ALZN) in Q4 2023, closing a stake of 12 shares — an estimated $4K sold.

Commonwealth Equity Services first reported a position in ALZN in Q4 2021 and held it in 8 quarters. The position peaked at $221K in Q4 2021. 14 funds tracked by Wall St. Rank hold ALZN as of Q4 2023.

  • Commonwealth Equity Services reported no remaining Alzamend Neuro position as of Q4 2023 after selling out during the quarter.
  • Commonwealth Equity Services sold 12 Alzamend Neuro shares in Q4 2023, an estimated $4K.
  • Commonwealth Equity Services first reported a position in Alzamend Neuro in Q4 2021 and held it in 8 quarters.
  • Commonwealth Equity Services's Alzamend Neuro position peaked at $221K in Q4 2021.
  • 14 funds tracked by Wall St. Rank held Alzamend Neuro as of Q4 2023.

Based on Commonwealth Equity Services's 13F filing for Q4 2023, filed 6 Feb 2024.